EPHX2 and Autoimmunity: Additionally, it will be useful to investigate how direct administration of ω-3/6 EpFAs modulates pathologic biomarkers of R-LPS-induced autoimmunity in female NZBWF1 mice, versus coadministration with ω-3/6 PUFAs and sEH inhibitor.